Literature DB >> 27680503

Endpoints in strategies to reduce polypharmacy.

Andrés Gaviria-Mendoza1, Jorge Enrique Machado-Alba1, Juan Pablo Castaño-Montoya1, Manuel Enrique Machado-Duque1, Claudia Giraldo-Giraldo1.   

Abstract

Mesh：

Year:  2016        PMID： 27680503      PMCID： PMC5237682          DOI： 10.1111/bcp.13122

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  7 in total

1.  [Results of an intervention to reduce potentially inappropriate prescriptions of beta blockers and calcium channel blockers].

Authors:  J E Machado-Alba; C Giraldo-Giraldo; A Aguirre Novoa
Journal:  Rev Calid Asist       Date:  2015-12-18

Review 2.  Age-related pharmacokinetic and pharmacodynamic changes and related risk of adverse drug reactions.

Authors:  A Corsonello; C Pedone; R A Incalzi
Journal:  Curr Med Chem       Date:  2010       Impact factor: 4.530

Review 3.  Impact of strategies to reduce polypharmacy on clinically relevant endpoints: a systematic review and meta-analysis.

Authors:  Tim Johansson; Muna E Abuzahra; Sophie Keller; Eva Mann; Barbara Faller; Christina Sommerauer; Jennifer Höck; Christin Löffler; Anna Köchling; Jochen Schuler; Maria Flamm; Andreas Sönnichsen
Journal:  Br J Clin Pharmacol       Date:  2016-05-07       Impact factor: 4.335

4.  Polytherapy and the risk of potentially inappropriate prescriptions (PIPs) among elderly and very elderly patients in three different settings (hospital, community, long-term care facilities) of the Friuli Venezia Giulia region, Italy: are the very elderly at higher risk of PIPs?

Authors:  Piergiorgio Cojutti; Luca Arnoldo; Giovanni Cattani; Silvio Brusaferro; Federico Pea
Journal:  Pharmacoepidemiol Drug Saf       Date:  2016-05-17       Impact factor: 2.890

5.  Endpoints in strategies to reduce polypharmacy.

Authors:  Andrés Gaviria-Mendoza; Jorge Enrique Machado-Alba; Juan Pablo Castaño-Montoya; Manuel Enrique Machado-Duque; Claudia Giraldo-Giraldo
Journal:  Br J Clin Pharmacol       Date:  2016-09-29       Impact factor: 4.335

Review 6.  Clinical consequences of polypharmacy in elderly.

Authors:  Robert L Maher; Joseph Hanlon; Emily R Hajjar
Journal:  Expert Opin Drug Saf       Date:  2013-09-27       Impact factor: 4.250

7.  [Intervention in the prescribing of the combination of an angiotensin converting enzyme inhibitor and an angiotensin-II receptor blocker].

Authors:  Alfredo Portilla; Daniel Torres; Manuel Enrique Machado-Duque; Jorge Enrique Machado-Alba
Journal:  Aten Primaria       Date:  2015-10-29       Impact factor: 1.137
  7 in total
  3 in total

1.  Reply to 'Endpoints in strategies to reduce polypharmacy'.

Authors:  Tim Johansson; Maria Flamm; Andreas Sönnichsen
Journal:  Br J Clin Pharmacol       Date:  2016-10-04       Impact factor: 4.335

2.  Endpoints in strategies to reduce polypharmacy.

Authors:  Andrés Gaviria-Mendoza; Jorge Enrique Machado-Alba; Juan Pablo Castaño-Montoya; Manuel Enrique Machado-Duque; Claudia Giraldo-Giraldo
Journal:  Br J Clin Pharmacol       Date:  2016-09-29       Impact factor: 4.335

3.  Reducing potentially inappropriate drug prescribing in nursing home residents: effectiveness of a geriatric intervention.

Authors:  Charlène Cool; Philippe Cestac; Cécile McCambridge; Laure Rouch; Philipe de Souto Barreto; Yves Rolland; Maryse Lapeyre-Mestre
Journal:  Br J Clin Pharmacol       Date:  2018-05-14       Impact factor: 4.335
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.